Related by context. Frequent words. (Click for all words.) 67 elotuzumab 66 heavily pretreated 65 ponatinib 65 PROMACTA 65 Secondary endpoints include 64 romidepsin 64 pertuzumab 64 tumor lysis syndrome 64 nab paclitaxel 64 tanespimycin 63 iclaprim 63 RECIST criteria 63 chlorambucil 63 eniluracil 63 registrational 62 IMGN# 62 pharmacodynamic effects 62 NVA# 62 talabostat 62 axitinib 62 HER2 positive metastatic breast 61 Azedra 61 SABCS 61 patients evaluable 61 cytogenetic response 61 Phase Ib clinical 61 indolent NHL 61 NEBIDO 61 relapsed multiple myeloma 61 BNC# 61 Phenoptin 61 FDA approvable letter 61 DAVANAT 61 deforolimus 61 relapsed refractory multiple myeloma 61 hypercalcemia 60 decitabine 60 superficial bladder cancer 60 IND submission 60 Amrubicin 60 eltrombopag 60 plus prednisone 60 AZX# 60 aflibercept 60 OncoVEX GM CSF 60 diabetic neuropathic pain 60 Secondary endpoints included 60 pazopanib 60 neoadjuvant 60 placebo controlled clinical 60 abiraterone acetate 60 Jevtana 60 alvimopan 60 anticancer compound 60 Sym# 60 AP# [003] 60 APOPTONE 60 Laquinimod 59 active comparator 59 teduglutide 59 randomized Phase III 59 goserelin 59 Pivotal Phase III 59 evaluable 59 QNEXA 59 SinuNase 59 NOXAFIL 59 DMARD 59 registrational trial 59 Carfilzomib 59 ofatumumab 59 vandetanib 59 biologic therapy 59 evaluable patients 59 OXi# 59 palifosfamide 59 atacicept 59 xenograft models 59 SUTENT 59 maribavir 59 composite endpoint 59 FOLFIRI 59 PXD# 59 nilotinib 59 Phase 1b trial 59 dasatinib 59 metastatic hormone refractory 59 mg kg dose 59 Solid Tumors 59 azacitidine 59 Act PDUFA date 59 Phase IIa trial 59 talactoferrin 59 dose cohorts 59 CoFactor 59 placebo controlled clinical trials 59 PS# [001] 59 dose limiting toxicities 58 tocilizumab 58 figitumumab 58 INTELENCE